Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression

REFERENCES

• Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase poly-merase chain reaction. J Clin Oncol 1994; 12: 475— 82.
   PubMedGoogle Scholar
• Kräger W, Krzizanowski C, Holweg M, Stockschläder M, Kr6ger N, Jung R, Mross K, Jonat W, Zander AR. Reverse transcriptase/ polymerase chain reaction detection of cytoker-atin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 1996; 122: 679–86.
   Google Scholar
• Moscinski LC, Trudeau WL, Fields KK, Elfenbein GJ. High-sensitivity detection of mini-mal residual breast carcinoma using the polymer-ase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 1996; 5: 173–80.
   PubMedGoogle Scholar
• Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC. Clinical signifi-cance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemo-therapy and autologous bone marrow transplanta-tion. J Clin Oncol 1996; 14: 1868–76.
   PubMed Web of Science ®Google Scholar
• Gunn J, McCall JL, Yun K, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996; 75: 611 — 6.
   PubMedGoogle Scholar
• Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet J-C, Sacks N, Bender HG, Luqmani Y, Coombes RC. The detection of micrometastases in peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reac-tion for keratin 19. Eur J Cancer 1997; 33: 854 — 61.
   Google Scholar
• Aihara T, Noguchi S, Ishikawa 0, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997; 72: 408–11.
   Google Scholar
• Krismann M, Todt B, Schröder J, Gareis D, MUller K-M, Seeber S, Schiitte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hemato-genous lung cancer dissemination. J Clin Oncol 1995; 13: 2769–75.
   Google Scholar
• Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71: 278–81.
   PubMedGoogle Scholar
• Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Guiliano AE, Cote R, Hoon DSB. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 2632–40.
   Google Scholar
• Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 1993; 142: 1111— 8.
   Google Scholar
• Lopez-Guerrero JA, Bolufer-Gilabert P, Sanz-Alonso M, Barragán-González E, Palau-Pérez J, de la Rubia-Comos J, Sempere-Talens A, Bonanad-Boix S. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin Chim Acta 1997; 263: 105–16.
   PubMedGoogle Scholar
• Novaes M, Bendit I, Garicochea B, del Giglio A. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. Mol Pathol 1997; 50: 209–11.
   Google Scholar
• Savtchenko ES, Schiff TA, Jiang CK, Freedberg IM, Blumenberg M. Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence. Am J Hum Genet 1988; 43: 630 — 7.
   Google Scholar
• Ruud P, Fodstad 0, Hovig E. Identification of a novel cytokeratin 9 pseudogene that may interfere with reverse transcriptase-polymerase chain reac-tion assays used to detect metastatic tumor cells. Int J Cancer 1999; 80: 119–25.
   Google Scholar
• Slade MJ, Smith BM, Sinnnett HD, Cross NCP, Coombs RC. Quantitative polymerase chain reac-tion for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999; 17: 870–9.
   Google Scholar
• Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929–36.
   PubMed Web of Science ®Google Scholar
• Spiessl B, editor. International Union Against Cancer. Illustrated guide to the TNM/pTNM classification of malignant tumours. TNM Atlas. 3rd ed. 2nd revision. Berlin: Springer Verlag, 1992.
   Google Scholar
• Cross NCP, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of bcr-abl fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186 — 9.
   PubMedGoogle Scholar
• Bor MV, Sorensen BS, Rammer P, Nexo E. Calibrated user-friendly reverse transcriptase-PCR assay: quantitation of epidermal growth factor receptor mRNA. Clin Chem 1998; 44: 1154–60.
   PubMed Web of Science ®Google Scholar
• Tschentscher P, Wagener C, Neumaier M. Sensi-tive and specific cytokeratin 18 reverse tran-scription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA. Clin Chem 1997; 43: 2244–50.
   Google Scholar
• Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–8.
   PubMed Web of Science ®Google Scholar
• Dostal DE, Rothblum KN, Baker KM. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: determination of renin and angiotensin mRNA levels in various tissues. Anal Biochem 1994; 223: 239— 50.
   Google Scholar
• Dassi C, Signorini S, Gerthoux P, Cazzaniga M, Brambilla P. Cytochrome P450 IBI mRNA measured in blood mononuclear cells by quanti-tative reverse transcriptase-PCR. Clin Chem 1998; 44: 416–21.
   Google Scholar
• Corey E, Arfman EW, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal compe-titive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997; 43: 443–52.
   PubMedGoogle Scholar
• Bader BL, Jahn L, Franke WW. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 1988; 47: 300–19.
   Google Scholar